{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:23:04Z","timestamp":1791890584420,"version":"4.3.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T00:00:00Z","timestamp":1655942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T00:00:00Z","timestamp":1655942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["108-2926-I-002-002-MY4"],"award-info":[{"award-number":["108-2926-I-002-002-MY4"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The optimal management of very small vessel (reference diameter from 2.0 to 2.25\u00a0mm) in percutaneous coronary interventions (PCIs) is controversial. We aimed to compare the efficacy and safety of drug-coated balloons (DCBs) and drug-eluting stents (DESs) for de-novo very small vessel interventions. We conducted a retrospective analysis of consecutive patients who received very small vessel PCI with a DCB or DES between January 2018 and March 2021. The outcome measures were the incidence of ischemia-driven target lesion revascularization (TLR) and major adverse cardiac and cerebrovascular events (MACCEs) within 1\u00a0year after PCI. MACCEs were defined as the composite of ischemia-driven TLR, all-cause death, non-fatal acute coronary syndrome, stroke, or heart failure requiring hospitalization. A total of 205 patients undergoing PCI with a DCB or DES were enrolled in this study. The procedural complication rate was 2.5% in the DES group and 1.7% in the DCB group (P\u2009=\u20091.000). After 1-year of follow-up, the cumulative incidence of TLR was 7.2% in the DCB group and 4.9% in the DES group (P\u2009=\u20090.530). The cumulative incidence of MACCEs was 10.6% in the DCB group and 12.7% in the DES group (P\u2009=\u20090.769). Only female gender, acute coronary syndrome on presentation, and dual antiplatelet therapy duration\u2009&lt;\u20093\u00a0months were significantly associated with MACCEs at 1\u00a0year, but the use of DCB or DES was not. The use of DCBs or DESs in de novo very small vessel intervention was not associated with different outcomes at 1\u00a0year.<\/jats:p>","DOI":"10.1038\/s41598-022-14047-7","type":"journal-article","created":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T15:04:16Z","timestamp":1655996656000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Comparison between drug-coated balloons and drug-eluting stents in very small coronary artery interventions"],"prefix":"10.1038","volume":"12","author":[{"given":"Cheng-Hsuan","family":"Tsai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Fan","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Wei","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Sheng","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao-Shin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Chang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Kai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Ping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Hsien","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsien-Li","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,23]]},"reference":[{"key":"14047_CR1","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1016\/S0735-1097(98)00444-6","volume":"32","author":"T Akiyama","year":"1998","unstructured":"Akiyama, T. et al. Angiographic and clinical outcome following coronary stenting of small vessels: A comparison with coronary stenting of large vessels. J. Am. Coll. Cardiol. 32, 1610\u20131618 (1998).","journal-title":"J. Am. Coll. Cardiol."},{"key":"14047_CR2","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S0735-1097(99)00181-3","volume":"34","author":"H Schunkert","year":"1999","unstructured":"Schunkert, H., Harrell, L. & Palacios, I. F. Implications of small reference vessel diameter in patients undergoing percutaneous coronary revascularization. J. Am. Coll. Cardiol. 34, 40\u201348 (1999).","journal-title":"J. Am. Coll. Cardiol."},{"key":"14047_CR3","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.jcin.2011.07.016","volume":"4","author":"BE Claessen","year":"2011","unstructured":"Claessen, B. E. et al. Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials. JACC Cardiovasc. Interv. 4, 1209\u20131215. https:\/\/doi.org\/10.1016\/j.jcin.2011.07.016 (2011).","journal-title":"JACC Cardiovasc. Interv."},{"key":"14047_CR4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ahj.2016.02.020","volume":"176","author":"LC van der Heijden","year":"2016","unstructured":"van der Heijden, L. C. et al. Small-vessel treatment with contemporary newer-generation drug-eluting coronary stents in all-comers: Insights from 2-year DUTCH PEERS (TWENTE II) randomized trial. Am. Heart J. 176, 28\u201335. https:\/\/doi.org\/10.1016\/j.ahj.2016.02.020 (2016).","journal-title":"Am. Heart J."},{"key":"14047_CR5","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1016\/j.jcin.2018.09.009","volume":"11","author":"Y Tang","year":"2018","unstructured":"Tang, Y. et al. Drug-coated balloon versus drug-eluting stent for small-vessel disease: The RESTORE SVD china randomized trial. JACC Cardiovasc. Interv. 11, 2381\u20132392. https:\/\/doi.org\/10.1016\/j.jcin.2018.09.009 (2018).","journal-title":"JACC Cardiovasc. Interv."},{"key":"14047_CR6","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1001\/jamacardio.2019.1776","volume":"4","author":"RA Buiten","year":"2019","unstructured":"Buiten, R. A. et al. Outcomes in patients treated with thin-strut, very thin-strut, or ultrathin-strut drug-eluting stents in small coronary vessels: A prespecified analysis of the randomized BIO-RESORT trial. JAMA Cardiol. 4, 659\u2013669. https:\/\/doi.org\/10.1001\/jamacardio.2019.1776 (2019).","journal-title":"JAMA Cardiol."},{"key":"14047_CR7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","volume":"40","author":"FJ Neumann","year":"2019","unstructured":"Neumann, F. J. et al. 2018 ESC\/EACTS Guidelines on myocardial revascularization. Eur. Heart J. 40, 87\u2013165. https:\/\/doi.org\/10.1093\/eurheartj\/ehy394 (2019).","journal-title":"Eur. Heart J."},{"key":"14047_CR8","doi-asserted-by":"publisher","first-page":"E277","DOI":"10.1002\/ccd.27996","volume":"93","author":"M Megaly","year":"2019","unstructured":"Megaly, M. et al. Outcomes with drug-coated balloons in small-vessel coronary artery disease. Catheter Cardiovasc. Interv. 93, E277\u2013E286. https:\/\/doi.org\/10.1002\/ccd.27996 (2019).","journal-title":"Catheter Cardiovasc. Interv."},{"key":"14047_CR9","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/j.jcin.2020.02.043","volume":"13","author":"RV Jeger","year":"2020","unstructured":"Jeger, R. V. et al. Drug-coated balloons for coronary artery disease: Third report of the international DCB consensus group. JACC Cardiovasc. Interv. 13, 1391\u20131402. https:\/\/doi.org\/10.1016\/j.jcin.2020.02.043 (2020).","journal-title":"JACC Cardiovasc. Interv."},{"key":"14047_CR10","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1016\/j.jacc.2011.08.007","volume":"58","author":"GN Levine","year":"2011","unstructured":"Levine, G. N. et al. 2011 ACCF\/AHA\/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J. Am. Coll. Cardiol. 58, e44\u2013e122. https:\/\/doi.org\/10.1016\/j.jacc.2011.08.007 (2011).","journal-title":"J. Am. Coll. Cardiol."},{"key":"14047_CR11","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1089\/jwh.2019.7826","volume":"29","author":"H Patel","year":"2020","unstructured":"Patel, H. et al. Microvascular disease and small-vessel disease: The nexus of multiple diseases of women. J. Womens Health (Larchmt) 29, 770\u2013779. https:\/\/doi.org\/10.1089\/jwh.2019.7826 (2020).","journal-title":"J. Womens Health (Larchmt)"},{"key":"14047_CR12","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1161\/01.cir.94.8.1818","volume":"94","author":"KE Kip","year":"1996","unstructured":"Kip, K. E. et al. Coronary angioplasty in diabetic patients. The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation 94, 1818\u20131825. https:\/\/doi.org\/10.1161\/01.cir.94.8.1818 (1996).","journal-title":"Circulation"},{"key":"14047_CR13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jjcc.2013.06.015","volume":"63","author":"C Ertan","year":"2014","unstructured":"Ertan, C. et al. Association of prediabetes with diffuse coronary narrowing and small-vessel disease. J. Cardiol. 63, 29\u201334. https:\/\/doi.org\/10.1016\/j.jjcc.2013.06.015 (2014).","journal-title":"J. Cardiol."},{"key":"14047_CR14","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1161\/01.cir.93.4.652","volume":"93","author":"NJ O'Connor","year":"1996","unstructured":"O\u2019Connor, N. J., Morton, J. R., Birkmeyer, J. D., Olmstead, E. M. & O\u2019Connor, G. T. Effect of coronary artery diameter in patients undergoing coronary bypass surgery. Northern New England Cardiovascular Disease Study Group. Circulation 93, 652\u2013655. https:\/\/doi.org\/10.1161\/01.cir.93.4.652 (1996).","journal-title":"Circulation"},{"key":"14047_CR15","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1093\/ejcts\/ezr105","volume":"41","author":"SJ Head","year":"2012","unstructured":"Head, S. J. et al. Incidence, predictors and outcomes of incomplete revascularization after percutaneous coronary intervention and coronary artery bypass grafting: A subgroup analysis of 3-year SYNTAX data. Eur. J. Cardiothorac. Surg. 41, 535\u2013541. https:\/\/doi.org\/10.1093\/ejcts\/ezr105 (2012).","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"14047_CR16","doi-asserted-by":"publisher","first-page":"915","DOI":"10.2147\/VHRM.S8161","volume":"6","author":"S Rathore","year":"2010","unstructured":"Rathore, S. Small coronary vessel angioplasty: Outcomes and technical considerations. Vasc. Health Risk Manag. 6, 915\u2013922. https:\/\/doi.org\/10.2147\/VHRM.S8161 (2010).","journal-title":"Vasc. Health Risk Manag."},{"key":"14047_CR17","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1016\/j.jcin.2018.10.018","volume":"11","author":"A Serra","year":"2018","unstructured":"Serra, A. Value of drug-coated balloons in small-vessel disease: Have they come of age?. JACC Cardiovasc. Interv. 11, 2393\u20132395. https:\/\/doi.org\/10.1016\/j.jcin.2018.10.018 (2018).","journal-title":"JACC Cardiovasc. Interv."},{"key":"14047_CR18","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1016\/j.jacc.2012.09.020","volume":"60","author":"A Latib","year":"2012","unstructured":"Latib, A. et al. A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: The BELLO (Balloon Elution and Late Loss Optimization) study. J. Am. Coll. Cardiol. 60, 2473\u20132480. https:\/\/doi.org\/10.1016\/j.jacc.2012.09.020 (2012).","journal-title":"J. Am. Coll. Cardiol."},{"key":"14047_CR19","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.jcin.2015.04.008","volume":"8","author":"A Latib","year":"2015","unstructured":"Latib, A. et al. 3-Year follow-up of the balloon elution and late loss optimization study (BELLO). JACC Cardiovasc. Interv. 8, 1132\u20131134. https:\/\/doi.org\/10.1016\/j.jcin.2015.04.008 (2015).","journal-title":"JACC Cardiovasc. Interv."},{"key":"14047_CR20","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0140-6736(18)31719-7","volume":"392","author":"RV Jeger","year":"2018","unstructured":"Jeger, R. V. et al. Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): An open-label randomised non-inferiority trial. Lancet 392, 849\u2013856. https:\/\/doi.org\/10.1016\/S0140-6736(18)31719-7 (2018).","journal-title":"Lancet"},{"key":"14047_CR21","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1111\/joic.12333","volume":"29","author":"DA Sinaga","year":"2016","unstructured":"Sinaga, D. A. et al. Drug-coated balloons: A safe and effective alternative to drug-eluting stents in small vessel coronary artery disease. J. Interv. Cardiol. 29, 454\u2013460. https:\/\/doi.org\/10.1111\/joic.12333 (2016).","journal-title":"J. Interv. Cardiol."},{"key":"14047_CR22","first-page":"256","volume":"30","author":"HW Sim","year":"2018","unstructured":"Sim, H. W. et al. Treatment of very small de novo coronary artery disease with 2.0 mm drug-coated balloons showed 1-year clinical outcome comparable with 2.0 mm drug-eluting stents. J. Invasive Cardiol. 30, 256\u2013261 (2018).","journal-title":"J. Invasive Cardiol."},{"key":"14047_CR23","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.jcmg.2013.04.014","volume":"6","author":"T Kubo","year":"2013","unstructured":"Kubo, T. et al. OCT compared with IVUS in a coronary lesion assessment: The OPUS-CLASS study. JACC Cardiovasc. Imaging 6, 1095\u20131104. https:\/\/doi.org\/10.1016\/j.jcmg.2013.04.014 (2013).","journal-title":"JACC Cardiovasc. Imaging"},{"key":"14047_CR24","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.atherosclerosis.2015.10.088","volume":"247","author":"R Naito","year":"2016","unstructured":"Naito, R. et al. Gender difference in long-term clinical outcomes following percutaneous coronary intervention during 1984\u20132008. Atherosclerosis 247, 105\u2013110. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.10.088 (2016).","journal-title":"Atherosclerosis"},{"key":"14047_CR25","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.amjcard.2011.04.009","volume":"108","author":"JE van Velzen","year":"2011","unstructured":"van Velzen, J. E. et al. Comparison of the relation between the calcium score and plaque characteristics in patients with acute coronary syndrome versus patients with stable coronary artery disease, assessed by computed tomography angiography and virtual histology intravascular ultrasound. Am. J. Cardiol. 108, 658\u2013664. https:\/\/doi.org\/10.1016\/j.amjcard.2011.04.009 (2011).","journal-title":"Am. J. Cardiol."},{"key":"14047_CR26","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.atherosclerosis.2014.05.920","volume":"235","author":"K Shimamura","year":"2014","unstructured":"Shimamura, K. et al. Difference of ruptured plaque morphology between asymptomatic coronary artery disease and non-ST elevation acute coronary syndrome patients: An optical coherence tomography study. Atherosclerosis 235, 532\u2013537. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.05.920 (2014).","journal-title":"Atherosclerosis"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14047-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14047-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14047-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T06:12:04Z","timestamp":1669356724000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14047-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,23]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["14047"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-14047-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,23]]},"assertion":[{"value":"10 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10679"}}